ARTICLE | Top Story

Obama asks for modest FDA budget bump

February 3, 2015 2:42 AM UTC

The Obama administration's FY16 budget request proposes small increases in appropriations for FDA's medical product review centers, and targets most of the new funds for efforts to combat antibiotic-resistant bacteria and to develop a regulatory framework for precision medicine.

The request would boost the budget of the Center for Drug Evaluation and Research (CDER) by $2.4 million, while reducing funds for "targeted, lower priority enforcement activities" by $4 million. CDER would increase spending on antibiotic resistance by $5 million in FY16, with funds earmarked to "support CDER's efforts to streamline clinical trial protocols, continue end point development, develop novel clinical trial designs, and facilitate the establishment of a clinical trial network as a part of the National Strategy for Combating Antibiotic Resistant Bacteria." The budget request also notes that CDER's funding from user fees would increase by $31 million to $887 million in FY16. ...